Megan E. Klatt, PharmD, BCIDP, DPLA

home / authors / megan-klatt-pharmd

Megan E. Klatt, PharmD, BCIDP, DPLA, is an infectious diseases/ antimicrobial stewardship clinical pharmacist at The University of Kansas Health System in Kansas City, KS.

Articles

Updates in the Treatment of Mycobacterium Tuberculosis

Updates in the Treatment of Mycobacterium Tuberculosis

Lindsey M. Childs-Kean, PharmD, MPH, BCPS;Megan E. Klatt, PharmD, BCIDP, DPLA
March 3rd 2025

The latest Bench to Bedside column reviews new guidance on the treatment of drug-susceptible and drug-resistance Mycobacterium tuberculosis infections.

Read More

Optimizing Antibiotic Use by Limiting Total Antibiotic Exposure

Optimizing Antibiotic Use by Limiting Total Antibiotic Exposure

Megan E. Klatt, PharmD, BCIDP, DPLA ;Erin K. McCreary, PharmD, BCPS, BCIDP*
February 21st 2022

Shorter durations of antibiotic therapy demonstrate similar efficacy and may improve safety compared with longer courses for certain infections.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?
Published: March 9th 2025 | Updated: March 13th 2025
Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?
The M&M Study: Age-Related T Cell Response in People with HIV on ART in MVA.HIVconsvX Vaccine Trial
Published: March 10th 2025 | Updated: March 13th 2025
The M&M Study: Age-Related T Cell Response in People with HIV on ART in MVA.HIVconsvX Vaccine Trial
The CM Study: Bivalent HIV Vaccine Induces Stronger T Cell Responses in People with HIV on ART
Published: March 10th 2025 | Updated: March 13th 2025
The CM Study: Bivalent HIV Vaccine Induces Stronger T Cell Responses in People with HIV on ART
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIV
Published: March 10th 2025 | Updated: March 13th 2025
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIV
HIV and Hepatitis Groups Ask Supreme Court to Protect PrEP, Testing
Published: March 4th 2025 | Updated: March 13th 2025
HIV and Hepatitis Groups Ask Supreme Court to Protect PrEP, Testing
© 2025 MJH Life Sciences

All rights reserved.